Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine

The purpose of this study was to evaluate the feasibility of using the expression profile of transforming growth factor beta (TGF-β-1-3) to assess the progression of L/S spine degenerative disease. The study group consisted of 113 lumbosacral (L/S) intervertebral disc (IVD) degenerative disease pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Rafał Staszkiewicz, Dorian Gładysz, Dawid Sobański, Filip Bolechała, Edward Golec, Małgorzata Sobańska, Damian Strojny, Artur Turek, Beniamin Oskar Grabarek
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/46/11/763
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846153850013089792
author Rafał Staszkiewicz
Dorian Gładysz
Dawid Sobański
Filip Bolechała
Edward Golec
Małgorzata Sobańska
Damian Strojny
Artur Turek
Beniamin Oskar Grabarek
author_facet Rafał Staszkiewicz
Dorian Gładysz
Dawid Sobański
Filip Bolechała
Edward Golec
Małgorzata Sobańska
Damian Strojny
Artur Turek
Beniamin Oskar Grabarek
author_sort Rafał Staszkiewicz
collection DOAJ
description The purpose of this study was to evaluate the feasibility of using the expression profile of transforming growth factor beta (TGF-β-1-3) to assess the progression of L/S spine degenerative disease. The study group consisted of 113 lumbosacral (L/S) intervertebral disc (IVD) degenerative disease patients from whom IVDs were collected during a microdiscectomy, whereas the control group consisted of 81 participants from whom IVDs were collected during a forensic autopsy or organ harvesting. Hematoxylin and eosin staining was performed to exclude degenerative changes in the IVDs collected from the control group. The molecular analysis consisted of reverse-transcription real-time quantitative polymerase chain reaction (RT-qPCR), an enzyme-linked immunosorbent assay (ELISA), Western blotting, and an immunohistochemical analysis (IHC). In degenerated IVDs, we noted an overexpression of all TGF-β-1-3 mRNA isoforms with the largest changes observed for TGF-β3 isoforms (fold change (FC) = 19.52 ± 2.87) and the smallest for TGF-β2 (FC = 2.26 ± 0.16). Changes in the transcriptional activity of TGF-β-1-3 were statistically significant (<i>p</i> < 0.05). Significantly higher concentrations of TGF-β1 (2797 ± 132 pg/mL vs. 276 ± 19 pg/mL; <i>p</i> < 0.05), TGF-β2 (1918 ± 176 pg/mL vs. 159 ± 17 pg/mL; <i>p</i> < 0.05), and TGF-β3 (2573 ± 102 pg/mL vs. 152 ± 11 pg/mL) were observed in degenerative IVDs compared with the control samples. Determining the concentration profiles of TGF-β1-3 appears to be a promising monitoring tool for the progression of degenerative disease as well as for evaluating its treatment or developing new treatment strategies with molecular targets.
format Article
id doaj-art-24b9effd46d749f5a6e2bca0d14a2a35
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-24b9effd46d749f5a6e2bca0d14a2a352024-11-26T17:58:02ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452024-11-014611128131282910.3390/cimb46110763Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the SpineRafał Staszkiewicz0Dorian Gładysz1Dawid Sobański2Filip Bolechała3Edward Golec4Małgorzata Sobańska5Damian Strojny6Artur Turek7Beniamin Oskar Grabarek8Collegium Medicum, WSB University, 41-300 Dabrowa Gornicza, PolandDepartment of Neurosurgery, 5th Military Clinical Hospital with the SP ZOZ Polyclinic in Krakow, 30-901 Cracow, PolandCollegium Medicum, WSB University, 41-300 Dabrowa Gornicza, PolandDepartment of Forensic Medicine, Jagiellonian University Medical College, 31-531 Cracow, PolandDepartment of Rehabilitation in Orthopaedics, Faculty of Motor Rehabilitation, Bronisław Czech University of Physical Education, 31-571 Krakow, PolandCollegium Medicum, WSB University, 41-300 Dabrowa Gornicza, PolandCollegium Medicum, WSB University, 41-300 Dabrowa Gornicza, PolandChair and Department of Biopharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 41-200 Sosnowiec, PolandCollegium Medicum, WSB University, 41-300 Dabrowa Gornicza, PolandThe purpose of this study was to evaluate the feasibility of using the expression profile of transforming growth factor beta (TGF-β-1-3) to assess the progression of L/S spine degenerative disease. The study group consisted of 113 lumbosacral (L/S) intervertebral disc (IVD) degenerative disease patients from whom IVDs were collected during a microdiscectomy, whereas the control group consisted of 81 participants from whom IVDs were collected during a forensic autopsy or organ harvesting. Hematoxylin and eosin staining was performed to exclude degenerative changes in the IVDs collected from the control group. The molecular analysis consisted of reverse-transcription real-time quantitative polymerase chain reaction (RT-qPCR), an enzyme-linked immunosorbent assay (ELISA), Western blotting, and an immunohistochemical analysis (IHC). In degenerated IVDs, we noted an overexpression of all TGF-β-1-3 mRNA isoforms with the largest changes observed for TGF-β3 isoforms (fold change (FC) = 19.52 ± 2.87) and the smallest for TGF-β2 (FC = 2.26 ± 0.16). Changes in the transcriptional activity of TGF-β-1-3 were statistically significant (<i>p</i> < 0.05). Significantly higher concentrations of TGF-β1 (2797 ± 132 pg/mL vs. 276 ± 19 pg/mL; <i>p</i> < 0.05), TGF-β2 (1918 ± 176 pg/mL vs. 159 ± 17 pg/mL; <i>p</i> < 0.05), and TGF-β3 (2573 ± 102 pg/mL vs. 152 ± 11 pg/mL) were observed in degenerative IVDs compared with the control samples. Determining the concentration profiles of TGF-β1-3 appears to be a promising monitoring tool for the progression of degenerative disease as well as for evaluating its treatment or developing new treatment strategies with molecular targets.https://www.mdpi.com/1467-3045/46/11/763intervertebral discintervertebral disc degenerationtransforming growth factor beta
spellingShingle Rafał Staszkiewicz
Dorian Gładysz
Dawid Sobański
Filip Bolechała
Edward Golec
Małgorzata Sobańska
Damian Strojny
Artur Turek
Beniamin Oskar Grabarek
Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
Current Issues in Molecular Biology
intervertebral disc
intervertebral disc degeneration
transforming growth factor beta
title Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
title_full Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
title_fullStr Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
title_full_unstemmed Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
title_short Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
title_sort assessment of the concentration of transforming growth factor beta 1 3 in degenerated intervertebral discs of the lumbosacral region of the spine
topic intervertebral disc
intervertebral disc degeneration
transforming growth factor beta
url https://www.mdpi.com/1467-3045/46/11/763
work_keys_str_mv AT rafałstaszkiewicz assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT doriangładysz assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT dawidsobanski assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT filipbolechała assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT edwardgolec assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT małgorzatasobanska assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT damianstrojny assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT arturturek assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine
AT beniaminoskargrabarek assessmentoftheconcentrationoftransforminggrowthfactorbeta13indegeneratedintervertebraldiscsofthelumbosacralregionofthespine